Article
FDA Approves First CRISPR Gene Editing Treatment for Sickle Cell Disease
Rating:
0.0
Views:
57
Likes:
1
Library:
1
Most people with sickle cell disease who received a new gene editing treatment saw their pain resolve for at least one year, but longer follow up is needed
Rate This Post
-
Education
-
Communication
-
Entertainment
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value